Apoptosis by influenza viruses correlates with efficiency of viral mRNA synthesis

Virus Research

Volumn 77, Issue 1, 2001, Pages 3-17

  Stray, Stephen J ^a,b,c   Air, Gillian M ^a  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

Author keywords

A NWS Mvi; Apoptosis; Influenza virus

Indexed keywords

ANTIVIRUS AGENT; INFLUENZA VIRUS HEMAGGLUTININ; SIALIDASE; VIRUS MESSENGER RNA;

ANIMAL CELL; APOPTOSIS; CONFERENCE PAPER; CONTROLLED STUDY; CORRELATION FUNCTION; DRUG EFFECT; INFLUENZA VIRUS; INOCULATION; INTERNALIZATION; MEMBRANE FUSION; MESSENGER RNA SYNTHESIS; NONHUMAN; PH; PRIORITY JOURNAL; RNA TRANSCRIPTION; VIROGENESIS; VIRUS MUTANT; VIRUS NUCLEOCAPSID; VIRUS REPLICATION;

ANIMALS; APOPTOSIS; CELL LINE; DOGS; HUMANS; INFLUENZA A VIRUS; INFLUENZA, HUMAN; MEMBRANE FUSION; MUTATION; RNA, MESSENGER; RNA, VIRAL;

INFLUENZA VIRUS; INFLUENZAVIRUS A;

EID: 0034935681     PISSN: 01681702     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-1702(01)00260-X     Document Type: Article

References (53)

1. Bound simian virus 40 translocates to caveolin-enriched membrane domains, and its entry is inhibited by drugs that selectively disrupt caveolae
2. Generation and characterization of a mutant of influenza A virus selected with the neuraminidase inhibitor BCX-140
3. Survival of FimH-expressing enterobacteria in macrophages relies on glycolipid traffic
4. The N2 neuraminidase of human influenza virus has acquired a substrate specificity complementary to the hemagglutinin receptor specificity
5. Generation and characterization of an influenza virus neuraminidase mutant with decreased sensitivity to the neuraminidase -specific inhibitor 4-Guanidino-Neu5Ac2en
6. Influenza virus uncoating in infected cells and effect of rimantadine
7. Mucins and mucoids in relation to influenza virus action. IV. Inhibition by purified mucoid of infection and hemagglutinin with the virus strain WSE
8. Changes in influenza virus associated with adaptation to passage in chick embryos
9. Studies on the Hirst haemagglutination reaction with influenza and Newcastle disease viruses
10. Quantitative aspects of influenza virus multiplication
11. Receptor specificity in human, avian and equine H2 and H3 influenza virus isolates
12. Fusion mutants of the influenza virus hemagglutinin glycoprotein
13. The clathrin endocytic pathway in viral infection
14. Virus clearance through apoptosis-dependent phagocytosis of influenza A virus-infected cells by macrophages
15. The specific enzyme of influenza virus and Vibrio choleræ
16. On the entry of Semliki Forest virus into BHK-21 cells
17. Hypertonic media inhibit receptor-mediated endocytosis by blocking clathrin-coated pit formation
18. Apoptosis: A mechanism of cell killing by influenza A and B viruses
19. Influenza A viruses lacking sialidase activity can undergo multiple cycles of replication in cell culture, eggs, or mice
20. Differences in sialic acid-galactose linkages in the chicken-egg amnion and allantois influence human influenza virus receptor specificity and variant selection
21. Direct sequencing of the HA gene of influenza (H3N2) virus in original clinical samples reveals sequence identity with mammalian cell-grown virus
22. Postreassortment changes in influenza A virus hemagglutinin restoring functional HA-NA match
23. Amino acid sequence changes in antigenic variants of type A influenza virus N2 neuraminidase
24. Adaptation of egg-grown and transfectant influenza viruses for growth in mammalian cells: Selection of hemagglutinin mutants with elevated pH of membrane fusion
25. Selection and characterization of a neuraminidase-minus mutant of influenza virus and its rescue by cloned neuraminidase genes
26. Influenza type A virus neuraminidase does not play a role in viral entry, replication, assembly or budding
27. Infectious entry of influenza virus in a canine kidney cell line
28. Avian influenza A viruses differ from human viruses by recognition of sialyloligosaccarides and gangliosides and by a higher conservation of the HA receptor-binding site
29. Action of cytochalasin D on cells of established lines I. Early events
30. Role of neuraminidase in influenza virus-induced apoptosis
31. Studies on the mechanism of influenza virus entry into cells
32. Receptor determinants of human and animal influenza virus isolates: Differences in the receptor specificity of the H3 hemagglutinin based on species of origin
33. Single amino acid substitutions in influenza hæmagglutinin change receptor binding specificity
34. Early stages of influenza virus entry into Mv-1 lung cells: Involvement of dynamin
35. Filipin-sensitive caveolae-mediated transport in endothelium: Reduced transcytosis, scavenger endocytosis, and capillary permeability of select macromolecules
36. Influenza virus neuraminidase activates latent transforming growth factor β
37. Effects of inhibitors of the cytoplasmic structures and functions on the early phase of infection of cultured cells with Simian virus 40
38. Changes in the conformation of influenza virus hemagglutinin at the pH optimum of virus-mediated fusion
39. Molecular basis for the resistance of influenza viruses to 4-guanidino-Neu5Ac2en
40. Amantadine selection of a mutant influenza virus containing an acid-stable hemagglutinin glycoprotein: Evidence for virus-specific regulation of the pH of glycoprotein transport vesicles
41. Influenza virus infection of desialylated cells
42. Entry pathway of vesicular stomatitis virus into different host cells
43. Activation of the apoptotic Fas antigen-encoding gene upon influenza virus infection involving spontaneously produced beta-interferon
44. Simian virus 40 infection is not mediated by lysosomal activation
45. Structure of the influenza virus hemagglutinin complexed with its receptor, sialic acid
46. Aggregation of microtubule subunit protein: The effects of divalent cations, colchicine and vinblastine
47. Studies of influenza hemagglutinin-mediated membrane fusion
48. Hemagglutinin specificity and neuraminidase coding capacity of neuraminidase-deficient influenza viruses
49. Infectious cell entry mechanism of influenza virus
50. Expression of functional influenza virus A polymerase proteins and template from cloned cDNAs in recombinant vaccinia virus infected cells
51. Early phase in the infection of cultured cells with papillomavirus virions
52. Identification of two distinct regulatory regions adjacent to the human β-interferon gene